REFERENCES
1 Griffin CA, Hawkins AL, Dvorak C, Henkle C, Ellingham T, Perlman EJ.
Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
Cancer Res. 1999 Jun 15;59(12):2776-80. PMID: 10383129.
2 Brodlie M, Barwick SC, Wood KM, McKean MC, Welch A. Inflammatory
myofibroblastic tumours of the respiratory tract: paediatric case series
with varying clinical presentations. J Laryngol Otol. 2011
Aug;125(8):865-8. doi: 10.1017/S0022215111000648. Epub 2011 Apr 12.
PMID: 21481297
3 Bahadori M, Liebow AA. Plasma cell granulomas of the lung. Cancer
1973;31:191–208
4 Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where
are we now? J Clin Pathol (2008) 61(4):428–37.10.1136/jcp.2007.049387
5 Höhne S, Milzsch M, Adams J, Kunze C, Finke R. Inflammatory
pseudotumor (IPT) and inflammatory myofibroblastic tumor (IMT): a
representative literature review occasioned by a rare IMT of the
transverse colon in a 9-years-old child. Tumor (2015)
101:249–56.10.5301/tj.5000353]
6 Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumor. WHO
Classification of Tumours of Soft Tissue and Bone. IARC; Lyon: 2013.
7 Donner LR, Trompler RA, White RR 4th. Progression of inflammatory
myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into
sarcoma after several recurrences. Hum Pathol. 1996 Oct;27(10):1095-8.
doi: 10.1016/s0046-8177(96)90291-9. PMID: 889259
8 Morotti RA, Legman MD, Kerkar N, Pawel BR, Sanger WG, Coffin CM.
Pediatric inflammatory myofibroblastic tumor with late metastasis the
lung: case report and review of the literature. Pediatr Dev Pathol
2005;8:224–9
9 Dishop MK, Kuruvilla S. Primaryand metastatic lung tumors in the
pediatric population: a review and 25-year experience at a large
children’s hospital. Arch Pathol Lab Med 2008;132: 1079–10
10 Casanova M, Brennan B, Alaggio R, Kelsey A, Orbach D, van Noesel MM,
Corradini N, Minard-Colin V, Zanetti I, Bisogno G, Gallego S, Merks JHM,
De Salvo GL, Ferrari A. Inflammatory myofibroblastic tumor: The
experience of the European pediatric Soft Tissue Sarcoma Study Group
(EpSSG). Eur J Cancer. 2020 Mar;127:123-129.
11 Zapatero J, Lago J, Madrigal L, Baschwitz B, Perez Rodriguez E,
Penalver R, Candelas J. Subglottic inflammatory pseudotumor in a
6-year-old child. Pediatr Pulmonol. 1989;6(4):268-71. doi:
10.1002/ppul.1950060411. PMID: 2748224
12 Aijaz F, Salam AU, Muzaffar S, et al: Inflammatory pseudotumor of the
trachea: Report of a case in an eight-year-old child. J Laryngology
Otology 108:613-616, 1994
13 Storck M, Liewald F, Heymer B, et al: Inflammatory pseudotumor of the
lung and trachea. Zentralbl Chir 120:650-656, 1995
14 Dewar AL, Connet GJ: Inflammatory Pseudotumor of the Trachea in a
Ten-Month-Old Infant. Pediatr Pulmonol 23:307-309, 1997
15 BumberZ, JurlinaM, Manojlovic ̵́S, Jakic ̵́-RJ. Inflammatory pseudotumor
of the trachea. J Pediatr Surg 2001; 36:631 – 634.
16 Chan PW, Omar KZ, Ramanujam TM. Successful treatment of unresectable
inflammatory pseudotumor of the lung with COX-2 inhibitor. Pediatr
Pulmonol (2003) 36:167–9.10.1002/ppul.103
17 Hoseok I, Joungho H, Ahn KM, Lee SI, Jhingook K. Complete surgical
resection of inflammatory myofibroblastic tumor with carinal
reconstruction in a 4-year-old boy. J Pediatr
Surg (2005) 40:e23–5.10.1016/j.jpedsurg.2005.08.043
18 Sivanandan S, Lodha R, Agarwala S, Sharma M, Kabra SK. Inflammatory
myofibroblastic tumor of the trachea. Pediatr
Pulmonol (2007) 42:847–50.10.1002/ppul.20651
19 Venizelos I, Papathomas T, Anagnostou E, Tsanakas J, Kirvassilis F,
Kontzoglou G. Pediatric inflammatory myofibroblastic tumor of the
trachea: a case report and review of the literature. Pediatr
Pulmonol (2008) 43:831–5.10.1002/ppul.20869
20 Breen DP, Dubus JC, Chetaille B, Payan MJ, Dutau H. A rare cause of
an endobronchial tumour in children: the role of interventional
bronchoscopy in the diagnosis and treatment of tumours while preserving
anatomy and lung
function. Respiration (2008) 76:444–8.10.1159/000101718
21 Lizarbe MO, Olascoaga JH, García ER, Castiella TM, Sagaseta de
Ilúrdoz Uranga María M, Garicano JM. Paediatric myofibroblastic tumours.
A presentation of three cases. An Pediatr
(Barc) (2009) 71:331–5.10.1016/j.anpedi.2009.06.010
22 Ochs K, Hoksch B, Frey U, Schmid RA. Inflammatory myofibroblastic
tumour of the lung in a five-year-old girl. Interact Cardiovasc
Thorac Surg (2010) 10:805–6.10.1510/icvts.2009.219089
23 Sacco O, Gambini C, Gardella C, Tomà P, Rossi UG, Jassoni V, et
al. “Atypical steroid response” in a pulmonary: inflammatory
myofibroblastic tumor. Pediatr
Pulmonol (2010) 45:721–6.10.1002/ppul.21237
24 Brodlie M, Barwick SC, Wood KM, McKean MC, Welch A. Inflammatory
myofibroblastic tumours of the respiratory tract: paediatric case series
with varying clinical presentations. J Laryngol Otol (2011)
125:865–8.10.1017/S0022215111000648
25 El-Desoky T, Nasef N, Osman E, Osman A, Zaki A, Zalata
K. Endobronchial inflammatory pseudotumor: a rare cause of a
pneumothorax in children. J Bronchology Interv
Pulmonol (2013) 20:256–60.10.1097/LBR.0b013e31829bccba
26 Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E,
Griffin CA. ALK1 and p80 expression and chromosomal rearrangements
involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol (2001)
14
27 Mossé YP, Voss SD, Lim MS, et al. Targeting ALK With Crizotinib in
Pediatric Anaplastic Large Cell Lymphoma and Inflammatory
Myofibroblastic Tumor: A Children’s Oncology Group Study. J Clin Oncol.
2017;35(28):3215-3221. doi:10.1200/JCO.2017.73.4830
28 Mossé YP Anaplastic Lymphoma Kinase as a Cancer Target in Pediatric
Malignancies.
Clin Cancer Res. 2016 Feb 1; 22(3):546-52
29 Butrynski JE, D’Adamo DR, Hornick JL, Dal Cin P, Antonescu CR,
Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ, Ramaiya N, Kwak EL, Clark
JW, Wilner KD, Christensen JG, Jänne PA, Maki RG, Demetri GD, Shapiro
GI. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N
Engl J Med.
30 Mosse’ YP, Lim MS, Voss SD, et al. Safety and activity of crizotinib
for paediatric patients with refractory solid tumours or anaplastic
large-cell lymphoma: a Children’s Oncology Group phase 1 consortium
study Lancet Oncol, 14 (2013), pp. 472-480
31 Sufliarsky, H.A. Gelderblom, et al. Prospective, non-randomized,
multicenter, phase 2 trial of crizotinib in patients with advanced,
inoperable inflammatory myofibroblastic tumor with and without
anaplastic lymphoma kinase gene alterations: EORTC study 90101 CREATE
Lancet Respiratory Medicine, 6 (2018), pp. 431-441).
32 Brivio E, C.M. Zwaan ALK inhibition in two emblematic cases of
pediatric inflammatory myofibroblastic tumor: efficacy and side effects
Pediatr Blood Cancer, 66 (5) (2019 May)
33 Craig E, Wiltsie Laura M, Lynda K. Beaupin, Ayesha Baig,
Rafalkozielski David, H. Rothstein, Veetail Li, Clare J.Twistm Matthew
Barth Anaplastic lymphoma kinase inhibitor therapy in the treatment of
inflammatory myofibroblastic tumors in pediatric patients: Case reports
and literature review, Journal of Pediatric Surgery , Feb 2021
34 Siminovich M, Galluzzo L, López J, Lubieniecki F, de Dávila MT.
Inflammatory myofibroblastic tumor of the lung in children: anaplastic
lymphoma kinase (ALK) expression and clinico-pathological correlation.
Pediatr Dev Pathol. 2012 May-Jun;15(3):179-86. doi:
10.2350/11-10-1105-OA.1. Epub 2012 Jan 26. PMID: 22280150.)
35 Antonescu CM, Suurmeijer A. JH, Zhang L,Sung YS, Jungbluth AA, Travis
WD, Al-Ahmadie H,, Fletcher C, Alaggio R.Molecular Characterization of
Inflammatory Myofibroblastic Tumors with Frequent ALK and ROS1 Fusions
and Rare Novel RET Gene Rearrangement. Am J Surg Pathol. 2015
Jul;39(7):957-67. doi: 10.1097/PAS.0000000000000404. PMID: 25723109;
PMCID: PMC4465992.
36 Lovly CM, Gupta A, Lipson D, Otto G, Brennan T, Chung CT, Borinstein
SC, Ross JS, Stephens PJ, Miller VA, Coffin CM) Inflammatory
myofibroblastic tumors harbor multiple potentially actionable kinase
fusions. Cancer Discov. 2014 Aug; 4(8):889-95